Long-term tumor control after repeat gamma-knife radiosurgery for pituitary adenomas
Author Information
Author(s): Felicia Lindberg, Alexander Gabri, Helena Kristiansson, Michael Gubanski, Charlotte Höybye, Martin Olsson, Petter Förander, Simon Skyrman, Bodo Lippitz, Alexander Fletcher-Sandersjöö, Jiri Bartek
Primary Institution: Karolinska University Hospital, Stockholm, Sweden
Hypothesis
What is the long-term progression-free survival following repeated gamma-knife radiosurgery in patients with growing pituitary adenomas?
Conclusion
Repeat gamma-knife radiosurgery is a feasible treatment option for pituitary adenomas that continue to grow after initial treatment.
Supporting Evidence
- The 5-year progression-free survival rate was found to be 57%.
- Older age at the time of repeat GKRS was identified as a significant predictor of tumor growth.
- 35% of patients experienced tumor growth after repeat GKRS.
Takeaway
This study looked at patients with pituitary tumors that kept growing after their first treatment. It found that doing the treatment again can help control the tumors for a while.
Methodology
This was a retrospective, population-based cohort study of patients treated with repeat gamma-knife radiosurgery for recurrent pituitary adenomas from 1999 to 2022.
Potential Biases
The retrospective design and lack of standardized volumetric cutoff for tumor regrowth may introduce bias.
Limitations
The study's selective nature and small sample size may limit the generalizability of the findings.
Participant Demographics
The cohort had a median age of 57 years at repeat GKRS, with 39% being female.
Statistical Information
P-Value
0.036
Confidence Interval
1.02 – 1.21
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website